Join us in Seattle, one of the world’s hubs for immune cell therapy innovation, to explore cutting-edge advancements in engineered T-cell therapies. Learn about the successes and challenges driving the industry forward, and gain valuable insights into what’s next for this transformative science.
Program
5:30 p.m. – 6:00 p.m. Welcome and Networking
6:00 p.m. – 7:00 p.m. Panel Discussion
7:00 p.m. – 7:30 p.m. Q&A
7:30 p.m. – 8:00 p.m. Networking
Speakers
Michelle Blake, Vice President, Translational Sciences at Sonoma Biotherapeutics
Shari Kaiser, Executive Director, Cell Therapy Translational Research at Bristol Myers Squibb
Pricing Information
- Members: $20
- Student Members: Free
- Non-members*: $40
- Student Non-members*: $10